03May
Sermonix Pharmaceuticals Announces Dr. Anthony H. Wild As Board Chairman and Investor
Investment and New Board Leadership Will Support the Path to Commercialization for Investigational Drug, Lasofoxifene COLUMBUS, OH (May 3, 2016) – Sermonix Pharmaceuticals LLC, a specialty pharmaceutical company focused on the development and commercialization of emerging late-stage women’s health products, today announced Anthony H. Wild, Ph.D., as Chairman of the Board and also a [...]
Read more